Kraus Michael A
Department of Medicine, Division of Nephrology, Indiana University Medical School and Clarian Health, Indianapolis, IN 46202, USA.
Semin Dial. 2009 Mar-Apr;22(2):137-40. doi: 10.1111/j.1525-139X.2008.00558.x.
Often, too little consideration is given to the fluids used in all forms of continuous renal replacement therapy (CRRT). However, errors in fluid prescription, delivery, or creation can be rapidly fatal; in addition, fluid associated expenses can be the overriding cost in continuous renal replacement therapies. While a standard solution is frequently acceptable in most clinical circumstances, specific electrolyte and acid-base disturbances may direct changes in fluid delivery and composition. Decisions regarding fluids, whether dialysate versus replacement, including generation and composition of therapy are discussed in this review.
通常,人们对各种形式的连续性肾脏替代治疗(CRRT)中所使用的液体考虑得太少。然而,液体处方、输送或配制过程中的失误可能会迅速致命;此外,与液体相关的费用可能是连续性肾脏替代治疗中的首要成本。虽然在大多数临床情况下,标准溶液通常是可以接受的,但特定的电解质和酸碱紊乱可能会指导液体输送和成分的改变。本综述讨论了有关液体的决策,包括透析液与置换液的选择,以及治疗的产生和成分。